The Chemours Company CC
Set alert
13.16 USD -0.37 -2.73%
At close · Nov 2
13.30 +0.14 +1.06%
After hours · Nov 2, 4:41 PM ET
13.15 Day range 13.81
10.44 52-week range 28.67
- YTD
- +11.62%
- 1 year
- -1.72%
- Open
- 13.66
- Prev close
- 13.53
- Mkt cap
- 1.98B
- Vol
- 4.48M
- Avg vol
- 2.29M
- EPS
- -2.02
- P/E
- 0.00
- Div yield
- 2.59%
More statistics
- Low
- 13.15
- High
- 13.81
- Forward P/E
- 7.08
- Beta
- 1.47
- Short ratio
- 7.07
- Inst. own
- 91.34%
- Dividend
- 0.35
- Ex-div date
- Nov 15, 2026
- Earnings
- Nov 2, 2026
- 50-d avg
- 14.23
- 200-d avg
- 18.40
- 1y target
- 16.50
3M chart
Events in this range
- Aug 4, 2026Earnings: 0.42; estimate 0.4887; surprise -14.06%
- Aug 13, 2026Rating: JP Morgan · Neutral → Neutral
- Aug 14, 2026Dividend: 0.0875
- Sep 30, 2026Rating: Mizuho · Outperform → Outperform
- Oct 5, 2026Rating: UBS · Neutral → Neutral
- Oct 13, 2026Rating: Barclays · — → Equal-Weight
- Oct 14, 2026Downgrade: Mizuho · Outperform → Neutral
- Oct 20, 2026Rating: Truist Securities · Buy → Buy
- Nov 2, 2026Earnings: —; estimate 0.2662; surprise —%
Signals (10)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 22, 2026 | 1 week ago |
| RSI: Oversold | Oct 16, 2026 | 2 weeks ago |
| RSI: Oversold | Oct 14, 2026 | 2 weeks ago |
| MACD: Sell Signal | Oct 13, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 6, 2026 | 3 weeks ago |
| MACD: Sell Signal | Sep 29, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 22, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 15, 2026 | 1 month ago |
| MACD: Buy Signal | Aug 14, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 5, 2026 | 2 months ago |
Financial health
Altman Z-Score
1.17 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
5 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 5
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -4.6×
FY 2016 5y median 8.2× FY 2025
P/S 0.3×
FY 2016 5y median 0.7× FY 2025
P/B 7.1×
FY 2016 5y median 5.1× FY 2025
P/FCF 34.8×
FY 2016 5y median 10.6× FY 2025
EV/EBITDA 17.1×
FY 2016 5y median 8.9× FY 2025
EV/Sales 1.0×
FY 2016 5y median 1.1× FY 2025
FCF Yield 2.9%
FY 2016 5y median 4.0% FY 2025
Profitability
Gross Margin 15.5%
FY 2016 5y median 21.5% FY 2025
Operating Margin -0.1%
FY 2016 5y median 7.7% FY 2025
Net Margin -6.6%
FY 2016 5y median 1.5% FY 2025
ROE -154.4%
FY 2016 5y median 14.2% FY 2025
ROIC -0.1%
FY 2016 5y median 5.2% FY 2025
ROA -5.2%
FY 2016 5y median 1.1% FY 2025
Growth (YoY)
Revenue 0.4%
FY 2016 FY 2025
Operating Income -101.1%
FY 2016 FY 2025
EPS (diluted) -549.1%
FY 2016 FY 2025
Free Cash Flow 105.1%
FY 2016 FY 2025
Financial Health
Current Ratio 1.8×
FY 2016 5y median 1.7× FY 2025
Quick Ratio 0.8×
FY 2016 5y median 1.0× FY 2025
Debt / Equity 18.3×
FY 2016 5y median 5.8× FY 2025
Net Debt / EBITDA 11.8×
FY 2016 5y median 5.3× FY 2025
Interest Coverage -0.0×
FY 2016 5y median 1.7× FY 2025
Dividends
Dividend Yield 4.4%
FY 2016 5y median 3.2% FY 2025
Payout Ratio -20.2%
FY 2016 5y median 26.6% FY 2025
Annual · latest fiscal year ends 2025-12-31